Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.31877 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.34473 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.30142 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.25463 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.25608 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.33667 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.30734 | 11 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.28437 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.29534 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.29876 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.28672 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30393 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.27027 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.29821 | 12 |